Form 4: Colgate-Palmolive Director Harris C Martin Reports Stock and Option Grants
SEC Form 4 Filing
Director Harris C Martin reports receiving stock and option grants from Colgate-Palmolive on May 13, 2024.
Summary
- On May 13, 2024, Harris C Martin, a director of Colgate-Palmolive, reported transactions involving the company's stock.
- Martin acquired 1,905 shares of common stock at $0.00 per share as an annual director stock grant.
- He also received a stock option grant for 2,201 shares with an exercise price of $94.46, exercisable in equal annual installments over three years starting May 13, 2025.
- Following these transactions, Martin directly owns 21,204 shares of common stock and holds options for 2,201 shares.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing. It doesn't inherently convey positive or negative sentiment.
Positives
- The director's acquisition of stock and options aligns their interests with those of shareholders.
Industry Context
Form 4 filings are standard disclosures required by the SEC when insiders of a company (such as directors and officers) trade in the company's securities. These filings provide transparency to the market regarding insider activity.
Comparison to Industry Standards
- Director compensation packages often include a mix of salary, stock options, and stock grants.
- The specifics of these packages vary widely based on company size, industry, and individual contributions.
- Comparing Colgate-Palmolive's director compensation to that of peers like Procter & Gamble (PG) or Unilever (UL) would provide a more comprehensive understanding of its relative generosity.
Stakeholder Impact
- The stock and option grants align the director's interests with those of shareholders, potentially incentivizing decisions that increase shareholder value.
Key Dates
| Date | Description |
|---|---|
| 05/13/2024 | Date of stock and option grants. |
| 05/13/2025 | First anniversary of the grant date, when the options begin to vest. |
| 05/13/2032 | Expiration date of the stock options. |
| 05/15/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.